Vvus stock quote
VVUS Stock Price & Charts | VIVUS In depth view into VVUS (VIVUS) stock including the latest price, news, dividend history, earnings information and financials. VVUS VIVUS, Inc. Stock Quote - FINVIZ.com VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in
VVUS Stock Quote of Vivus Inc - InvestorPlace
5 Nov 2007 Vivus (VVUS) · VVUS RSS Feed · Add VVUS Price Alert Hide Sticky Hide Intro. Moderator:. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it 31 Dec 2019 31, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the an additional 1% of the outstanding shares of VIVUS common stock. 04 Apr 2020 4/3/2020 7:45 pm -- Open: 1.38 High: 1.41 Low: 1.38 Close: 1.41 1 / 1 0.7 1.4 2.1 2.8 3.5 4.2 0 250 500 750 1000 Mar 29 02 03 04 Mar 29 02 03 04. Name, Price, Change, % Change. S&P 500, 2584.59 VVUS, 3.07. -17.26%. 27,761 Stock quotes supplied by Six Financial & Barchart Quotes delayed at VIVUS, Inc. (VVUS) Stock Price, Quote, History & News ...
In depth view into VVUS (VIVUS) stock including the latest price, news, dividend history, earnings information and financials.
Detailed price information for Vivus Inc (VVUS-Q) from The Globe and Mail including charting and trades. Skip to main content Get full access to globeandmail.com
VIVUS - VVUS - Stock Price & News | The Motley Fool
5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio By Zacks Investment Research May 25, 2017 VIVUS is a biopharmaceutical company developing and commercializing innovative, next VIVUS, Inc. (VVUS) stock price, quote, history & news ... VIVUS, Inc. (VVUS), a biopharmaceutical company, today announced the publication of a new study from the Toolbox Trial (NCT01922934), a real-world clinical trial conducted in urban safety-net primary care clinics offering patients a “toolbox” of cost-effective weight management tools. VVUS | Stock Snapshot - Fidelity
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 7,218,750 shares of the Company’s common stock, at a purchase price of $1
VVUS stock quote, chart and news. Get VIVUS, Inc.'s stock price today. VIVUS, Inc. - TheStreet Vivus (VVUS) Stock Falls Following Earnings Release, Restructuring Plan. By Tony Owusu. Jul 31, 2015 3:25 PM EDT. INVESTING. 4 Stocks Under $10 Making Big Moves Higher. By Roberto Pedone. VVUS - VIVUS, Inc. Summary, Stock Quote and News | Benzinga Jan 01, 2010 · VIVUS, Inc. (NASDAQ: VVUS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. VIVUS, Inc. (VVUS) Stock Price, Quote, History & News ... VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 7,218,750 shares of the Company’s common stock, at a purchase price of $1
Stock quote for VIVUS, Inc. Common Stock Common Stock (VVUS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.